31
Jul

The FDA approved Boehringer Ingelheim’s COPD treatment Striverdi Respimat, a once-a-day inhaler the German drugmaker hopes can contend in a crowded respiratory market.

…read more

Source: Boehringer plays catch-up in COPD with its latest FDA approval

    

0 No comments